Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
Neuroinflammation is a major pathogenic component in most neurological diseases including: (6)
|
-multiple sclerosis
-alzheimer disease -stroke -HIV dementia -brain tumours -several peripheral neuopathies |
|
Which of the two contributing immune mechanisms of neuroinflammation: adaptive and innate predominates?
|
adaptive mechanisms
|
|
What three things dictate the type and severity of neuroinflammation? (3)
|
cell type involved, immunogen, and the host genetic background
|
|
Neuroinflammation can be initiated outside the CNS, or initiated within the CNS with what aiding it?
|
subsequent leukocyte infiltration or ensuing leukocyte infiltration
|
|
What may be counter-productive in the long term?
|
immuno-suppressants
|
|
What is a favourable therapeutic strategy for inflammation?
|
an anti-inflammatory drug with selective sparing of the beneficial aspects of inflammation
|
|
What are bone marrow-derived brain cells? What happens to them when disease-activated?
|
microglia, that proliferate when disease-activated
|
|
What is different about microglia in different locations?
|
morphology (eg. shape)
|
|
Function of normal microglia
|
immune sensors
|
|
Functions of activated microglia (7)
|
-phagocytosis
-chemotaxis -antigen presentation -cytotoxicity -morphological changes -proliferation -respiratory burst |
|
What is the most abundant cell in the brain?
|
astrocyte
|
|
Which cells contribute to the endogenous (2) and exogenous (5) aspects of innate immunity?
|
endogenous: microglia/macrophages, astrocytes
exogenous: neutrophils, mast cells, dendritic cells, NK and gamma cells |
|
What are the processes involved in adaptive immunity?
|
-cell-mediated immunity (CTL/CD8; DTH/CD4)
-antibody-dependent cell-mediated cytotoxicity -molecular mimicry (B and T cells) |
|
What are four potential antigen presenting cells in the brain, and which proteins are they involved with?
|
-astrocytes possible for MHC class I and II in vivo, and yes for both in vitro
-microglia, perivascular cells and other CNS macrophages possible for MHC class I, and yes for MHC class II in vivo |
|
What are seven mediators of neuroinflammation, and which two do not have anti-inflammatory types?
|
-interferons, cytokines, chemokines, eicosinoids, complement fragment, proteases, and neuropeptides
-chemokines and complement fragments don't have anti-inflammatory types |
|
What are two unique aspects of CNS infections?
|
-localization of the infection dictates the clinical presentation (CNS vs PNS)
-brain is an immune privileged organ with the blood brain barrier and innate (macrophages, neutrophils) vs adaptive (CTL and Abs) immunity |
|
General pathway to a neuroinvasion (5)
|
-viral entry
-growth in extraneural tissues -maintenance of viremia -choroid plexus to cerebrospinal fluid -small vessels to brain |
|
What are four primary replication sites, and five secondary sites?
|
-primary: subcutaneous tissue/muscle, lymph nodes, respiratory or gastrointestinal tract
-secondary: muscle, vascular endothelium, bone marrow, liver, or spleen |
|
Maintenance of viremia (2)
|
virus replication/amplification in leukocytes, and clearance by macrophages, neutrophils, and antibodies
|
|
How does a virus cross the blood brain barrier?
|
through the use of infected leukocytes
|
|
Which virus can infect neural cells, microglia, macrophages, and endothelia?
|
cytomegalovirus (CMV)
|
|
Which virus infects only the neurone?
|
vericella zoster virus (VZV)
|
|
Human endogenous retrovirus (HERVs)
|
present in germline for >30M years but usually replication defective and is mitogen stimulation-dependent gene expression
|
|
HERVs implications in autoimmune diseases (4)
|
multiple sclerosis (MS), systemic lupus erythematosus (SLE), primary biliary cirrhosis (PBC), and diabetes mellitus (IDDM)
|
|
Emerging neurological infections (5)
|
-variant CJD
-nipah virus encephalitis -west nile virus encephalitis -enterovirus 71 encephalitis -usually xenotropic and usually RNA viruses |
|
What is the presumed source of HIV-I?
|
chimpanzee
|
|
How many people are invected with HIV today, how many new infections each year worldwide, and in canada?
|
-42 million HIV positive today
-5 million new/year worldwide -4000 new infections/year in canada |
|
HIV is associated with which four factors of dementia/neurocognitive disorders?
|
memory loss, neuropsychiatric dysfunction, immune-deficiency, and motor abnormalities
|
|
HIV-associated dementia (HAD)
|
affects 10-20% of patients with HIV, usually after the development of aids and heralds a poorer survival prognosis
|
|
What usually proceeds HAD?
|
minor cognitive-motor disorder (MCMD)
|
|
Risk factors associated with HAD (4)
|
extremes of age, CCR5 32, APOE 4, polymorphisms in promoters of TNF-alpha and MCP-1
|
|
Highly active antiretroviral therapy (HAART)
|
used for cases of HIV, with some success where recovery is dependent on dementia severity and prior ART exposure (MSK scale)
|
|
Neuropathological features of HIV
|
-atrophy and white matter pallor
-mulrinucleated giant cells -perivascular cuffing -HIV antigen detection |
|
Expression of what gene is associated with severe dementia?
|
TNFalpha
|
|
Rank the blood-brain barrier perturbation in HIV infection for myelin, glia, and neurons.
|
+ve subcortical glia>+ve cortical neurons>diffuse myelin pallor
|
|
What are the cellular components in HIV neuropathogenesis passed form infected macrophage/microglia to apoptotic neuron? (5)
|
cytokines, ROS, MMPs, gp120, and Vpr
|
|
What are the cellular components in HIV neuropathogenesis passed from infected macrophage/microglia to activated astrocyte? (4)
|
cytokines, ROS, gp120, and Nef
|
|
What are the cellular components in HIV neuropathogenesis passed from a infected activated astrocyte to apoptotic neurone? (3)
|
cytokines, chemokines, and ROS
|
|
Neuroprotective drug treatments for HIV-related neurodisorders (6)
|
-NMDA receptor antagonists (memantidine/amantidine)
-minocycline -PAF/TNF inhibitors -valproate -growth hormone -SSRIs |
|
Symptomatic drug treatment for HIV-related neurodisorders (2)
|
quetiapine and olanzapine
|
|
What are herpes simplex virus encephalitis (HSE) annual incidence, mortality when reduced, and likelihood of reoccurrence?
|
-2-5/million annual
-mortality reduced to 20% with acyclovir -reoccurance is low >3% in adults |
|
What are two new techniques being explored in relation to neurological infection?
|
metagenomics and microarrays
|